Latest Regulatory News

Siren Gold has restarted drilling at its Sams Creek Project in New Zealand, aiming to expand its 824,000-ounce gold resource by targeting deeper porphyry structures and fold hinges. The company plans a focused drilling campaign and mining study in 2025 to unlock further value.

Wellnex Life Limited has locked in A$9 million in conditional commitments to support its proposed dual listing on the London Stock Exchange’s AIM market, alongside launching a 1:1 entitlement offer for existing shareholders.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.

Tivan Limited has formalised a Resourcing Protocol Agreement with the Kimberley Land Council, setting a clear path to negotiate an Indigenous Land Use Agreement for its Speewah Project.

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.

Global Lithium Resources Limited has refreshed its board following the 2025 AGM, appointing Dr Dianmin Chen as Managing Director and CEO to spearhead strategic milestones at the Manna Lithium Project and restore investor confidence.

FireFly Metals Ltd reported a reduced half-year loss of A$5.7 million for December 2024, bolstered by a significant increase in cash reserves and strategic asset acquisitions in Canada and Australia.

AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.

AMP Limited’s 2024 results reveal a 43% drop in statutory net profit to $150 million, offset by a 15.1% rise in underlying profit to $236 million, alongside the completion of its Advice business sale and the launch of a new digital bank.

GQG Partners Inc. has announced a quarterly ordinary dividend of USD 0.0378 per CDI, payable on March 27, 2025, with an option for Australian dollar conversion at a specified exchange rate.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.